About: covid:PMC7405405

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7405405 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Moreno, Fernando Jara, Carlos Algara, Manel Alés, Jose Chacón, José Cruz, Josefina Cruz‐Merino, Luis Filipovich, Elena García‐Sáenz, Jose Gimenez, Julia Guerrero‐Zotano, Angel Martin, Miguel Montero, Ángel Rojo, Federico Santisteban, Marta Tarruella, Sara
is schema:about of	named entity 'COVID' named entity 'During' named entity 'intensive care' named entity 'infection' named entity 'Celgene' named entity 'parenteral' named entity 'Eisai' named entity 'RNA' named entity 'chemotherapy' named entity 'higher risk' named entity 'evidence-based guidelines' named entity 'Novartis' named entity 'fulvestrant' named entity 'HER2' named entity 'Irradiation' named entity 'myelosuppression' named entity 'infection' named entity 'curative intention' named entity 'older patients' named entity 'prognoses' named entity 'Pfizer' named entity 'PCR' named entity 'agonists' named entity 'high-risk' named entity 'premenopausal' named entity 'antibodies' named entity 'chemotherapy' named entity 'receptor' named entity 'comorbidities' named entity 'bacterial infection' named entity 'body temperature' named entity 'Ki67' named entity 'myelosuppressive' named entity 'Novartis' named entity 'adjuvant' named entity 'first-line treatment' named entity 'lumpectomy' named entity 'COVID' named entity 'Amgen' named entity 'operating rooms' named entity 'irradiation' named entity 'trastuzumab' named entity 'anesthesia' named entity 'immunosuppression' named entity 'risk/benefit ratio' named entity 'HER2' named entity 'Novartis' named entity 'hematological' named entity 'tumor' named entity 'life expectancy' named entity 'comorbidity' named entity 'SARS-CoV-2' named entity 'Roche' named entity 'toxicity' named entity 'patient outcomes' named entity 'prognosis' named entity 'HER2' named entity 'oophorectomy' named entity 'radiotherapy' named entity 'SARS-CoV-2' named entity 'CDK4' named entity 'SARS-CoV-2' named entity 'hormone' named entity 'Antiangiogenic therapy' named entity 'Genentech' named entity 'receptor' named entity 'SARS-CoV-2' named entity 'lymph nodes' named entity 'IgM' named entity 'higher risk' named entity 'virus' named entity 'monotherapy' named entity 'tumor size' named entity 'exposure to the virus' named entity 'patent holder' named entity 'risk/benefit ratio' named entity 'infection' named entity 'Neoadjuvant chemotherapy' named entity 'personal protective equipment' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'Amgen' named entity 'tumors' named entity 'T-DM1'

Attributes

Values

Creator

Moreno, Fernando
Jara, Carlos
Algara, Manel
Alés, Jose
Chacón, José
Cruz, Josefina
Cruz‐Merino, Luis
Filipovich, Elena
García‐Sáenz, Jose
Gimenez, Julia
Guerrero‐Zotano, Angel
Martin, Miguel
Montero, Ángel
Rojo, Federico
Santisteban, Marta
Tarruella, Sara

is schema:about of

named entity 'COVID'
named entity 'During'
named entity 'intensive care'
named entity 'infection'
named entity 'Celgene'
named entity 'parenteral'
named entity 'Eisai'
named entity 'RNA'
named entity 'chemotherapy'
named entity 'higher risk'
named entity 'evidence-based guidelines'
named entity 'Novartis'
named entity 'fulvestrant'
named entity 'HER2'
named entity 'Irradiation'
named entity 'myelosuppression'
named entity 'infection'
named entity 'curative intention'
named entity 'older patients'
named entity 'prognoses'
named entity 'Pfizer'
named entity 'PCR'
named entity 'agonists'
named entity 'high-risk'
named entity 'premenopausal'
named entity 'antibodies'
named entity 'chemotherapy'
named entity 'receptor'
named entity 'comorbidities'
named entity 'bacterial infection'
named entity 'body temperature'
named entity 'Ki67'
named entity 'myelosuppressive'
named entity 'Novartis'
named entity 'adjuvant'
named entity 'first-line treatment'
named entity 'lumpectomy'
named entity 'COVID'
named entity 'Amgen'
named entity 'operating rooms'
named entity 'irradiation'
named entity 'trastuzumab'
named entity 'anesthesia'
named entity 'immunosuppression'
named entity 'risk/benefit ratio'
named entity 'HER2'
named entity 'Novartis'
named entity 'hematological'
named entity 'tumor'
named entity 'life expectancy'
named entity 'comorbidity'
named entity 'SARS-CoV-2'
named entity 'Roche'
named entity 'toxicity'
named entity 'patient outcomes'
named entity 'prognosis'
named entity 'HER2'
named entity 'oophorectomy'
named entity 'radiotherapy'
named entity 'SARS-CoV-2'
named entity 'CDK4'
named entity 'SARS-CoV-2'
named entity 'hormone'
named entity 'Antiangiogenic therapy'
named entity 'Genentech'
named entity 'receptor'
named entity 'SARS-CoV-2'
named entity 'lymph nodes'
named entity 'IgM'
named entity 'higher risk'
named entity 'virus'
named entity 'monotherapy'
named entity 'tumor size'
named entity 'exposure to the virus'
named entity 'patent holder'
named entity 'risk/benefit ratio'
named entity 'infection'
named entity 'Neoadjuvant chemotherapy'
named entity 'personal protective equipment'
named entity 'SARS-CoV-2'
named entity 'SARS-CoV-2'
named entity 'Amgen'
named entity 'tumors'
named entity 'T-DM1'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software